Angiogenesis is a complex process involving dynamic interaction of various cell to cell interactions. Endothelial cell inter-
New vessel formation derived from pre-existing vessels is called angiogenesis. It occurs through activation of quiescent endothelial cells upon stimulation. Endothelial activation is accompanied by instability of cell to cell junction. VE-cadherin, an endothelial specific junctional molecule, not only mediates adherence junctional formation, but also triggers intracellular signaling for cell dynamics and proliferation. Several transcriptional factors including FoxO1 and -catenin mediates VE-cadherin-induced signaling in genetic regulation. We identified YAP as an important transcriptional regulator that transduces signal from VE-cadherin mediated endothelial cell to cell contact to the nucleus. Our current study showed that in quiescent endothelial cells, VE-cadherin expression and clustering was important in maintaining the inactivated of YAP through phosphorylation. Disruption of VE-cadherin clustering or suppression of VE-cadherin expression resulted in the activation of YAP. We also showed that VE-cadherin dependent YAP phosphorylation required the activation of PI3K/Akt signaling pathway. Nuclear localization and transcriptional activity of YAP was increased by genetic or pharmacologic blockade of Akt pathway in confluent endothelial cells.
Angiopoietin-2 (ANG-2), an autocrine factor released from active endothelial cells, plays important role in vascular re-http://bmbreports.org modeling. Although it is well known that ANG-2 synthesis and secretion are dynamically regulated in endothelial cells, detailed mechanism of its regulation is not clearly understood. Here, we identified ANG-2 as a transcriptional target of YAP in endothelial cells. YAP and ANG-2 was co-localized in endothelial cells of mouse retina and tumor vessels. Reduced expression and overexpression of YAP in HUVECs resulted in a decrease and an increase of ANG-2 expression, respectively. Chromatin immunoprecipitation analysis and luciferase activity assay of ANG-2 promoter indicated that ANG-2 was transcriptionally regulated by YAP. The addition of recombinant ANG-2 protein partially compensated vascular defects caused by YAP depletion. Altogether, these results indicate that ANG-2 transcriptionally regulated by YAP in endothelial cells can promote vascular remodeling and angiogenesis in an autocrine way.
In conclusion, our results suggest that YAP plays significant roles in genetic regulation during vascular remodeling and sprouting (Fig. 1) . Angiogenesis starts from endothelial cell activation which accompanies dramatic changes in cell junctions, cytoskeleton, and gene expression. However, it has not been clearly defined on how these events are linked and cooperated. Since abnormal endothelial cell activation occurs in multiple pathophysiological conditions including tumor and inflammation, understanding the molecular mechanism that mediates endothelial cell junctional stability and activation is essential to the development of therapeutic means to improve these pathologic conditions. Although further studies are needed to understand what factors will destabilize endothelial junctions that affect YAP activity and how, our results revealed the role of YAP as a linker connecting endothelial cell junctional stability to genetic changes during vascular remodeling, thus providing further insight into the molecular mechanisms underlying the angiogenic activation of endothelial cells by YAP.
